Hs-CRP, albumin and CA19-9 after neoadjuvant therapy predict postoperative survival in borderline resectable pancreatic ductal adenocarcinoma. (2020) - Nurmi, A.; Mustonen, H.; Stenman, U.H.; Haglund, C.; Seppänen, H.